Heart Disease Clinical Trials in Maryland

Showing 441-460 of 497 trials

Cranberry Juice and Cardiovascular Disease

NCT01295684

Previous studies have shown that consumption of a low calorie cranberry beverage imparts a favorable impact on HDL cholesterol, LDL oxidation, and cell adhesion molecules in men. However, these studies were not well controlled. Thus, it is important to confirm these effects in a blinded, placebo-controlled feeding study. The investigators goal is to verify the cardioprotective effects of cranberries by conducting a dietary intervention trial with healthy subjects in a controlled environment.

Cardiovascular Disease

United States Department of Agriculture (USDA)60 participantsStarted Sep 2010

Beltsville, Maryland, United States

COMPLETEDPhase 313 miles

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

NCT00371709

TAXUS ATLAS is a global, multi-center, single-arm, non-inferiority trial comparing results from patients treated with the TAXUS Liberté stent to an historical TAXUS Express control. The control group is a case-matched, blended population of TAXUS Express patients from the TAXUS IV and TAXUS V de novo clinical trials. The objective of the study is to evaluate clinical outcomes of TAXUS Liberté-SR stent in de novo lesions and to assess the non-inferiority of TAXUS Liberté versus TAXUS Express. The TAXUS Liberté-SR stent is hypothesized to have comparable safety and efficacy to the TAXUS Express stent.

Coronary Artery Disease

Boston Scientific Corporation871 participantsStarted Aug 2004

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Beverly Hills, California, United States +59 more locations

Cranberry Juice and Cardiovascular Disease

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

Heart Disease Trials in Other Cities

Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

Rilonacept to Improve Artery Function in Patients With Atherosclerosis

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation

The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)

The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices

The Epidemiology of Ventricular Assist Device-Related Infections

Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]

Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe

Other Conditions in Maryland